Protecting the Consumer at the Heart of DTC Precision Medicine
Bill Of Health
OCTOBER 27, 2023
The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so. But especially as personalized medical services come to the forefront of the latest therapeutic revolutions, the Federal Trade Commission (FTC) should join that list.
62 
Let's personalize your content